Equity derivatives house of the year – Société Générale

Société Générale

marc-el-asmar

Equipping itself with products that thrive on the non-collapse of the equity market and showing the desire to extend the range of structured products it can sell to insurance and other institutional investors, Société Générale (SG) has once more laid down a marker in equity derivatives-based structured products.

A banner year for equities that started at the turn of 2013 has put a spring in the step of almost all structured products houses. SG, with the 40% of its structured products business

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here